Abbott Stock To Go Ex-dividend Tomorrow (ABT)

NEW YORK ( TheStreet) -- The ex-dividend date for Abbott Laboratories (NYSE: ABT) is tomorrow, July 11, 2013. Owners of shares as of market close today will be eligible for a dividend of 14 cents per share. At a price of $34.83 as of 9:30 a.m. ET, the dividend yield is 1.6%.

The average volume for Abbott has been 7.1 million shares per day over the past 30 days. Abbott has a market cap of $55.2 billion and is part of the health care sector and health services industry. Shares are up 8.1% year to date as of the close of trading on Tuesday.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Abbott as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, a generally disappointing performance in the stock itself and feeble growth in the company's earnings per share. You can view the full Abbott Ratings Report.

See our dividend calendar or top-yielding stocks list.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing